Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy for Primary Liver Tumors
NCT02291133Phase 2Completed
- Start
- Jun 2014
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bleomycin in hepatocellular carcinoma (HCC). Primary endpoint: Number of Participants With Toxicity Related to Electrochemotherapy at 7 days. Started Jun 2014; status: completed.
02
Drugs
bleomycin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02291133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291133.